KRYS - Krystal Biotech GAAP EPS of -$1.25 misses by $0.26 February, 27 2023 07:44 AM Krystal Biotech Inc. Krystal Biotech press release ( NASDAQ: KRYS ): Q4 GAAP EPS of -$1.25 misses by $0.26 . Cash, cash equivalents, and investments totaled $383.8 million on December 31, 2022. For further details see: Krystal Biotech GAAP EPS of -$1.25 misses by $0.26